Anti-Cytokeratin 1 + Cytokeratin 2e antibody [EPR27257-91],Abcam,AB315228

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Host

Rabbit

Reactivity

Human, Mouse

Application

mIHC, Dot, IHC-P, IHC-Fr

Platform ID

BAB838443085

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Abcam

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Email:

[email protected]

Product Specifications
Scientific Background

Specifications

NameAnti-Cytokeratin 1 + Cytokeratin 2e antibody [EPR27257-91]
Cat. No.AB315228
HostRabbit
IsotypeIgG
ReactivityHuman, Mouse
ApplicationmIHC, Dot, IHC-P, IHC-Fr
ClonalityMonoclonal
Clone NumberEPR27257-91
Concentration0.525 mg/mL Batch dependent concentration
ImmunogenThe exact immunogen used to generate this antibody is proprietary information.
PurityAffinity purification Protein A
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data May regulate the activity of kinases such as PKC and SRC via binding to integrin beta-1 (ITB1) and the receptor of activated protein C kinase 1 (RACK1). In complex with C1QBP is a high affinity receptor for kininogen-1/HMWK. See full target information KRT1 Additional targets KRT2

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.